Systematic Assessment of Fragment Identification for Multitarget Drug Design
Citations Over Time
Abstract
Designed multitarget ligands are a popular approach to generating efficient and safe drugs, and fragment-based strategies have been postulated as a versatile avenue to discover multitarget ligand leads. To systematically probe the potential of fragment-based multiple ligand discovery, we have employed a large fragment library for comprehensive screening on five targets chosen from proteins for which multitarget ligands have been successfully developed previously (soluble epoxide hydrolase, leukotriene A4 hydrolase, 5-lipoxygenase, retinoid X receptor, farnesoid X receptor). Differential scanning fluorimetry served as primary screening method before fragments hitting at least two targets were validated in orthogonal assays. Thereby, we obtained valuable fragment leads with dual-target engagement for six out of ten target combinations. Our results demonstrate the applicability of fragment-based approaches to identify starting points for polypharmacological compound development with certain limitations.
Related Papers
- → Hierarchical virtual screening approaches in small molecule drug discovery(2014)154 cited
- → Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats(2011)56 cited
- → Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery(2009)43 cited
- → Soluble Epoxide Hydrolase Inhibitors and/ or Epoxyeicosatrianoic Acids Attenuate Hyperalgesia and Allodynia in a Rat Model(2006)1 cited
- Progress on the Treatment for Hypertension of Epoxide Hydrolase and Its Mechanisms(2008)